Cardiovascular Risk After Preeclampsia
Recruiting
Observational Study
Preeclampsia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Female
- Study type
- Observational
- Participants needed
- 60 (estimated)
- Sponsor
- Charite University, Berlin, Germany · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Investigation of cardiovascular risk 5-15 years after early or late-onset preeclampsia by adenosine stress Magnetic Resonance Imaging and non-invasive methods like retinal vessel analysis, skin measurement of advanced glycation end products, flow-mediated dilation or pulse wave analysis in comparison to women after healthy pregnancies.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women
* 18-60 years
* 5-15 years postpartum
Exclusion Criteria:
* Atrioventricular block, chronic obstructive pulmonary disease, bronchial asthma
* Pregnancy and/or active breastfeeding
* Glaucoma disease, epilepsy
* In addition for MRI: metal implants, electric devices, int…
Contacts